Skip to content

Better postoperative pain management with epidural dexmedetomidine versus buprenorphine

Post-operative analgesic effectiveness of epidural Dexmedetomidine versusBuprenorphine- A randomized double blind clinical trial - PAEEDB

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011977
Enrollment
50
Registered
2018-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA physicalstatus I &II posted for elective lower abdominal surgeries

Interventions

Intervention1: epidural dexmedetomidine 1mcg/kg: patients in Group D- Dexmedetomidine group, will receive Dexmedetomidine (1.0mcgg / kg) constituted to 1ml with normal saline +7ml of 0.125% bupivacai

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients of ASA physical status I-II 2.Aged between 18 to 65 years of either sex.

Exclusion criteria

Exclusion criteria: 1.Contraindications to regional anesthesia: 2.Raised ICT 3.Patients refusal 4.local site infection 5.coagulation abnormalities, 6.allergy to local anaesthetics (amide group), 7.previous spine surgeries / spine deformities 8.Morbidly obese patients 9.neurologic, psychiatric disease, severe renal or hepatic derangement 10.Patients with history of drug abuse. 11.History of allergy or contraindications to either Dexmedetomidine or buprenorphine . 12.Concomitant use of medications which may exaggerate the heart rate response of Dexmedetomidine including digoxin or β-adrenergic antagonists. � Patients who are pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
analgesic effectivenessTimepoint: analgesic effectiveness

Secondary

MeasureTime frame
sedation,nausea, vomiting, pruritis, other side effects and hemodynamicsTimepoint: heart rate, blood pressure and respiratory rate recorded every 5min for first 30 min, every 10min for next 30min, every 15min next 60min and at every 30mins for next 4 hours.

Countries

India

Contacts

Public ContactDr Navya C N
drcn.navya@gmail.com9791793965

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026